Related Experiment Video
Updated: Jul 10, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
[Mumps in Poland in 2005]
1Zakład Epidemiologii Państwowego Zakładu Higieny ul. Chocimska 24, 00-791 Warszawa. pstefanoff@pzh.gov.pl
Abstract:
In 2005, 71,945 cases of mumps were reported in Poland. The incidence (188.5 per 100,000) was lower compared to 2004 (354.1), when the highest mumps incidence was recorded since 1999. The recently observed improvement in the epidemiological situation of mumps (trend towards lower and less frequent epidemic peaks) reflect the use of measles-mumps-rubella vaccine which was increasingly acquired by parents at their own expense during the last decade. Mandatory, free of charge, vaccination of children aged 13-14 months with trivalent measles-mumps-rubella vaccine was implemented at the end of 2003. The vaccination coverage among 3-year olds in 2005 reached 90.5%. Approximately 4.3% of cases were hospitalized (3105) and no deaths attributed to mumps were reported. Children 5-9 year old were the most affected age group (incidence 1569.7 per 100,000).
Insights
Mumps cases in Poland significantly decreased in 2005, reflecting the impact of the measles-mumps-rubella (MMR) vaccine. High vaccination coverage in children contributed to lower incidence and fewer outbreaks.
Area of Science:
- Epidemiology
- Vaccinology
Context:
- Poland reported 71,945 mumps cases in 2005, a decrease from previous years.
- Mumps incidence in 2005 was 188.5 per 100,000, lower than the peak in 2004.
Purpose:
- To analyze the epidemiological situation of mumps in Poland in 2005.
- To assess the impact of the measles-mumps-rubella (MMR) vaccine on mumps incidence.
Summary:
- The decline in mumps cases and epidemic peaks is attributed to the increased uptake of the MMR vaccine.
- Mandatory, free MMR vaccination for infants began in late 2003, achieving 90.5% coverage in 3-year-olds by 2005.
- The 5-9 year age group was most affected, with 4.3% of cases requiring hospitalization and no reported deaths.
Impact:
- The study highlights the effectiveness of widespread MMR vaccination in controlling mumps outbreaks.
- Sustained high vaccination coverage is crucial for maintaining reduced mumps incidence and preventing future epidemics.
Related Concept Videos
Poliomyelitis
Viral Meningitis
Cytomegalovirus Disease
Infectious Diseases and Their Occurrence
Toxoplasmosis
Arboviral Encephalitis

